loader image
Friday, December 19, 2025
75.4 F
McAllen
- Advertisement -

The Latest Advances in Dementia and Alzheimer’s Treatments and Research, Sept. 23rd

Presented by Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association

Translate to Spanish or other 102 languages!

The Information will be presented by Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association. Image Source: www.alz.org/
The Information will be presented by Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association. Image Source: www.alz.org/
- Advertisement -

EDINBURG, Texas – The Alzheimer’s Association San Antonio and South Texas Chapter proudly invites Rio Grande Valley residents to the Alzheimer’s & Dementia Research Update: The Latest in Alzheimer’s Disease Treatments and Research on September 23, 2025. The event will feature Dr. Maria C. Carrillo, Chief Science Officer, Alzheimer’s Association. Dr. Carrillo oversees the Association’s research initiatives, guiding efforts to accelerate progress in the prevention and treatment of Alzheimer’s and all other dementia. 

“We are proud to be partnering with DHR Health Institute for Research and Development and Methodist Healthcare Ministries to bring this event to the Rio Grande Valley,” says Marcie McDonald, Executive Director, Alzheimer’s Association San Antonio & South Texas Chapter. “Access to the latest information and resources is critical. We are incredibly fortunate to bring together such a distinguished group of local experts.”

This event, which is free and open all, will be held from 5:30 p.m. to 7:30 p.m. at the Edinburg Conference Center at the Renaissance. 

- Advertisement -

Following Dr. Carrillo’s Alzheimer’s & Dementia Research Update, there will be a Q&A session with Dr. Carrillo and DHR Health panelists including Dr. Scott Lillibridge, VP & CEO, DHR Health Research & Development Institute, Dr. Jose E. Igoa, Medical Director, DHR Health Behavioral Hospital and Dr. Roberto A. Cruz, Neurologist, DHR Health Neurology Institute and Dr. Monica M. Betancourt-Garcia, VP DHR Health Institute for Research & Development.

Caregivers, students, healthcare professionals, and community members interested in learning more about Alzheimer’s disease and the future of dementia care are invited to attend.

Continuing Education (CE) certificates will be available for Registered Nurses (RN), Certified Nursing Assistants (CNA), Social Workers (SW), Community Health Workers (CHW), and Long-Registration is required to receive CE certificates. 

Don’t miss this opportunity to hear directly from one of the nation’s leading voices in Alzheimer’s research as well as a distinguished group of local experts.

- Advertisement -

There is no charge for the Alzheimer’s & Dementia Research Update, but registration is highly recommended. Register today at bit.ly/ALZRUDHR. For more information or to register by phone, call our 24/7 Helpline at 800.272.3900.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×